Located on the campus of the Faculty of Health Sciences, the Boehringer Ingelheim Lung Institute provides clinical services as well as conducting research that is focused on epidemiology, allergy diagnostics, lung physiology, clinical pharmacology, evaluation of novel treatments and community-based interventions for improving disease management and improving health.
The Lung Institute operates as a not-for-profit financially self-sufficient public/private initiative, and continues to contribute meaningful clinical research into priority health issues for Southern Africa with the more than 380 scientific publications to date. In addition, the Knowledge Translation Unit has been able to improve the quality of primary healthcare through the implementation of evidence based clinical practice guidelines and training of more than 20,000 healthcare workers to date.
Eight active clinical trials in asthma, COPD and tuberculosis are underway. The knowledge transfer unit was established to educate South African healthcare workers in tuberculosis and will be extended to workers in sub-Saharan Africa. Doctors from universities / public sector are trained on clinical trial related activities, including clinical trial design, performance and reporting.
|Location||Southern Africa, South Africa|